アメリカの不妊症検査と治療市場予測　2021-2026年

UNITED STATES INFERTILITY TESTING & TREATMENT MARKET FORECAST 2021-2026

–

このレポートへお問合せ　　目次

この調査レポートはアメリカの不妊症 検査と治療市場を分析・予測したInkwood Researchの市場調査報告書です。

Overview

KEY FINDINGS
The United States infertility testing & treatment market is anticipated to record a CAGR of 12.20% during the forecast years. Factors such as technological advancements in IVF procedures, the increasing rates of infertility, and the surge in middle-age pregnancies, are among the key factors expected to propel the market growth of the country. The base year considered for the market study is 2020, and the estimated period is from 2021 to 2026.
MARKET INSIGHTS
Infertility testing and treatment is widely used across the United States, assisting couples with infertility issues, single mothers, and the LGBT community to procreate. The country’s market growth is significantly influenced by aspects like the surging trend of delayed pregnancies, the mounting success rates of IVF, the rise in infertility, and the increasing disposable income. However, the market in the United States is likely to be restricted by the complications associated with IVF, the high costs, and low awareness.
Several regions in the United States have necessitated infertility treatment coverage. Although specific federal laws to regulate the industry’s reimbursement scenario are not set, the IVF bills are introduced by the government. For instance, in 2009, Tennessee passed a bill redefining reimbursement in donor IVF practices. As per Merck Serono’s fertility report, a standard IVF cycle cost is nearly 50% of an individual’s annual income in the United States. However, the majority of employers and companies have not authorized the compensation of fertility services within individual states. Thus, these factors are set to influence the United States infertility testing & treatment market over the forecast years.
COMPETITIVE INSIGHTS
Leading companies operating in the market are Cook Medical Inc, CooperSurgical, Fujifilm Irvine Scientific, Progyny Inc, etc.
Our report offerings include:
– Explore key findings of the overall market
– Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
– Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
– Market Segmentation cater to a thorough assessment of key segments with their market estimations
– Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
– Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
– Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
– Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

目次

Table of Contents

TABLE OF CONTENTS
1. RESEARCH SCOPE & METHODOLOGY
1.1. STUDY OBJECTIVES
1.2. SCOPE OF STUDY
1.3. METHODOLOGY
1.4. ASSUMPTIONS & LIMITATIONS
2. EXECUTIVE SUMMARY
2.1. MARKET SIZE & ESTIMATES
2.2. COUNTRY SNAPSHOT
2.3. COUNTRY ANALYSIS
2.4. KEY GROWTH ENABLERS
2.5. KEY CHALLENGES
3. KEY ANALYTICS
3.1. IMPACT OF COVID-19 ON INFERTILITY TESTING & TREATMENT MARKET
3.2. KEY MARKET TRENDS
3.3. PORTER’S FIVE FORCES ANALYSIS
3.3.1. BUYERS POWER
3.3.2. SUPPLIERS POWER
3.3.3. SUBSTITUTION
3.3.4. NEW ENTRANTS
3.3.5. INDUSTRY RIVALRY
3.4. OPPORTUNITY MATRIX
3.5. KEY BUYING CRITERIA
3.5.1. TREATMENT OPTIONS
3.5.2. QUALITY OF MEDICAL PROCEDURES
3.5.3. PRICE OF TREATMENTS
3.5.4. SHIFT TOWARDS MEDICAL TOURISM
3.5.5. REIMBURSEMENT
3.6. REGULATORY FRAMEWORK
3.7. VALUE CHAIN ANALYSIS
3.7.1. RAW MATERIAL PROCUREMENT
3.7.2. MANUFACTURING
3.7.3. SUPPLY LOGISTICS
3.7.4. DISTRIBUTION CHANNELS
3.7.5. END-USERS
4. MARKET BY GENDER
4.1. MALE
4.1.1. MALE INFERTILITY TESTING
4.1.1.1. DNA FRAGMENTATION
4.1.1.2. OXIDATIVE STRESS ANALYSIS
4.1.1.3. SPERM PENETRATION ASSAY
4.1.1.4. COMPUTER-ASSISTED SEMEN ANALYSIS (CASA)
4.1.1.5. SPERM AGGLUTINATION
4.1.1.6. MICROSCOPIC EXAMINATION
4.1.1.7. OTHERS
4.1.2. MALE INFERTILITY TREATMENT
4.1.2.1. MEDICATION
4.1.2.2. ASSISTED REPRODUCTIVE TECHNOLOGY & VARICOCELE SURGERY
4.2. FEMALE
4.2.1. FEMALE INFERTILITY TESTING
4.2.1.1. OVULATION TESTING
4.2.1.2. HYSTEROSALPINGOGRAPHY
4.2.1.3. LAPAROSCOPY
4.2.1.4. TRANSVAGINAL ULTRASOUND
4.2.1.5. OVARIAN RESERVE TESTING
4.2.1.6. HORMONAL LEVEL TESTING
4.2.1.7. OTHERS
4.2.2. FEMALE INFERTILITY TREATMENT
4.2.2.1. IVF WITH ICSI
4.2.2.2. IUI
4.2.2.3. IVF WITHOUT ICSI
4.2.2.4. SURROGACY
4.2.2.5. OTHERS
5. MARKET BY END-USER
5.1. FERTILITY AND SURGICAL CENTERS
5.2. HOSPITALS AND RESEARCH LABORATORIES
5.3. CRYOBANKS
6. COMPETITIVE LANDSCAPE
6.1. KEY STRATEGIC DEVELOPMENTS
6.1.1. MERGERS & ACQUISITIONS
6.1.2. PRODUCT LAUNCHES & DEVELOPMENTS
6.1.3. PARTNERSHIPS & AGREEMENTS
6.2. COMPANY PROFILES
6.2.1. COOPER SURGICAL
6.2.2. COOK MEDICAL INC
6.2.3. EMD GROUP (MERCK KGAA)
6.2.4. ESCO MEDICAL
6.2.5. FUJIFILM IRVINE SCIENTIFIC
6.2.6. VITROLIFE AB

List of Tables

LIST OF TABLES
TABLE 1: MARKET SNAPSHOT – UNITED STATES INFERTILITY TESTING & TREATMENT
TABLE 2: REGULATORY FRAMEWORK
TABLE 3: UNITED STATES INFERTILITY TESTING & TREATMENT MARKET, BY GENDER, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 4: UNITED STATES INFERTILITY TESTING & TREATMENT MARKET, BY GENDER, FORECAST YEARS, 2021-2026 (IN $ MILLION)
TABLE 5: UNITED STATES INFERTILITY TESTING & TREATMENT MARKET, BY MALE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 6: UNITED STATES INFERTILITY TESTING & TREATMENT MARKET, BY MALE, FORECAST YEARS, 2021-2026 (IN $ MILLION)
TABLE 7: UNITED STATES INFERTILITY TESTING & TREATMENT MARKET, BY MALE INFERTILITY TESTING, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 8: UNITED STATES INFERTILITY TESTING & TREATMENT MARKET, BY MALE INFERTILITY TESTING, FORECAST YEARS, 2021-2026 (IN $ MILLION)
TABLE 9: PROS AND CONS OF DNA SHARING METHODS
TABLE 10: UNITED STATES INFERTILITY TESTING & TREATMENT MARKET, BY MALE INFERTILITY TREATMENT, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 11: UNITED STATES INFERTILITY TESTING & TREATMENT MARKET, BY MALE INFERTILITY TREATMENT, FORECAST YEARS, 2021-2026 (IN $ MILLION)
TABLE 12: UNITED STATES INFERTILITY TESTING & TREATMENT MARKET, BY FEMALE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 13: UNITED STATES INFERTILITY TESTING & TREATMENT MARKET, BY FEMALE, FORECAST YEARS, 2021-2026 (IN $ MILLION)
TABLE 14: UNITED STATES INFERTILITY TESTING & TREATMENT MARKET, BY FEMALE INFERTILITY TESTING, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 15: UNITED STATES INFERTILITY TESTING & TREATMENT MARKET, BY FEMALE INFERTILITY TESTING, FORECAST YEARS, 2021-2026 (IN $ MILLION)
TABLE 16: COST OF OVULATION TESTING KITS IN THE US
TABLE 17: UNITED STATES INFERTILITY TESTING & TREATMENT MARKET, BY FEMALE INFERTILITY TREATMENT, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 18: UNITED STATES INFERTILITY TESTING & TREATMENT MARKET, BY FEMALE INFERTILITY TREATMENT, FORECAST YEARS, 2021-2026 (IN $ MILLION)
TABLE 19: UNITED STATES INFERTILITY TESTING & TREATMENT MARKET, BY END-USER, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 20: UNITED STATES INFERTILITY TESTING & TREATMENT MARKET, BY END-USER, FORECAST YEARS, 2021-2026 (IN $ MILLION)

List of Figures

LIST OF FIGURES
FIGURE 1: KEY MARKET TRENDS
FIGURE 2: PORTER’S FIVE FORCES ANALYSIS
FIGURE 3: OPPORTUNITY MATRIX
FIGURE 4: VALUE CHAIN ANALYSIS
FIGURE 5: KEY BUYING CRITERIA
FIGURE 6: UNITED STATES INFERTILITY TESTING & TREATMENT MARKET, GROWTH POTENTIAL, BY GENDER, IN 2020
FIGURE 7: UNITED STATES INFERTILITY TESTING & TREATMENT MARKET, BY MALE, 2021-2026 (IN $ MILLION)
FIGURE 8: UNITED STATES INFERTILITY TESTING & TREATMENT MARKET, GROWTH POTENTIAL, BY MALE, IN 2020
FIGURE 9: UNITED STATES INFERTILITY TESTING & TREATMENT MARKET, BY MALE INFERTILITY TESTING, 2021-2026 (IN $ MILLION)
FIGURE 10: UNITED STATES INFERTILITY TESTING & TREATMENT MARKET, GROWTH POTENTIAL, BY MALE INFERTILITY TESTING, IN 2020
FIGURE 11: UNITED STATES INFERTILITY TESTING & TREATMENT MARKET, BY DNA FRAGMENTATION, 2021-2026 (IN $ MILLION)
FIGURE 12: CAUSES OF SPERM DNA FRAGMENTATION
FIGURE 13: UNITED STATES INFERTILITY TESTING & TREATMENT MARKET, BY OXIDATIVE STRESS ANALYSIS, 2021-2026 (IN $ MILLION)
FIGURE 14: UNITED STATES INFERTILITY TESTING & TREATMENT MARKET, BY SPERM PENETRATION ASSAY, 2021-2026 (IN $ MILLION)
FIGURE 15: UNITED STATES INFERTILITY TESTING & TREATMENT MARKET, BY COMPUTER-ASSISTED SEMEN ANALYSIS (CASA), 2021-2026 (IN $ MILLION)
FIGURE 16: UNITED STATES INFERTILITY TESTING & TREATMENT MARKET, BY SPERM AGGLUTINATION, 2021-2026 (IN $ MILLION)
FIGURE 17: UNITED STATES INFERTILITY TESTING & TREATMENT MARKET, BY MICROSCOPIC EXAMINATION, 2021-2026 (IN $ MILLION)
FIGURE 18: UNITED STATES INFERTILITY TESTING & TREATMENT MARKET, BY OTHERS, 2021-2026 (IN $ MILLION)
FIGURE 19: UNITED STATES INFERTILITY TESTING & TREATMENT MARKET, BY MALE INFERTILITY TREATMENT, 2021-2026 (IN $ MILLION)
FIGURE 20: UNITED STATES INFERTILITY TESTING & TREATMENT MARKET, GROWTH POTENTIAL, BY MALE INFERTILITY TESTING, IN 2020
FIGURE 21: UNITED STATES INFERTILITY TESTING & TREATMENT MARKET, BY MEDICATION, 2021-2026 (IN $ MILLION)
FIGURE 22: UNITED STATES INFERTILITY TESTING & TREATMENT MARKET, BY ASSISTED REPRODUCTIVE TECHNOLOGY & VARICOCELE SURGERY, 2021-2026 (IN $ MILLION)
FIGURE 23: UNITED STATES INFERTILITY TESTING & TREATMENT MARKET, BY FEMALE, 2021-2026 (IN $ MILLION)
FIGURE 24: UNITED STATES INFERTILITY TESTING & TREATMENT MARKET, GROWTH POTENTIAL, BY FEMALE, IN 2020
FIGURE 25: UNITED STATES INFERTILITY TESTING & TREATMENT MARKET, BY FEMALE INFERTILITY TESTING, 2021-2026 (IN $ MILLION)
FIGURE 26: UNITED STATES INFERTILITY TESTING & TREATMENT MARKET, GROWTH POTENTIAL, BY FEMALE INFERTILITY TESTING, IN 2020
FIGURE 27: UNITED STATES INFERTILITY TESTING & TREATMENT MARKET, BY OVULATION TESTING, 2021-2026 (IN $ MILLION)
FIGURE 28: UNITED STATES INFERTILITY TESTING & TREATMENT MARKET, BY HYSTEROSALPINGOGRAPHY, 2021-2026 (IN $ MILLION)
FIGURE 29: UNITED STATES INFERTILITY TESTING & TREATMENT MARKET, BY LAPAROSCOPY, 2021-2026 (IN $ MILLION)
FIGURE 30: UNITED STATES INFERTILITY TESTING & TREATMENT MARKET, BY TRANSVAGINAL ULTRASOUND, 2021-2026 (IN $ MILLION)
FIGURE 31: UNITED STATES INFERTILITY TESTING & TREATMENT MARKET, BY OVARIAN RESERVE TESTING, 2021-2026 (IN $ MILLION)
FIGURE 32: UNITED STATES INFERTILITY TESTING & TREATMENT MARKET, BY HORMONAL LEVEL TESTING, 2021-2026 (IN $ MILLION)
FIGURE 33: UNITED STATES INFERTILITY TESTING & TREATMENT MARKET, BY OTHERS, 2021-2026 (IN $ MILLION)
FIGURE 34: UNITED STATES INFERTILITY TESTING & TREATMENT MARKET, BY FEMALE INFERTILITY TREATMENT, 2021-2026 (IN $ MILLION)
FIGURE 35: UNITED STATES INFERTILITY TESTING & TREATMENT MARKET, GROWTH POTENTIAL, BY FEMALE INFERTILITY TREATMENT, IN 2020
FIGURE 36: UNITED STATES INFERTILITY TESTING & TREATMENT MARKET, BY IVF WITH ICSI, 2021-2026 (IN $ MILLION)
FIGURE 37: UNITED STATES INFERTILITY TESTING & TREATMENT MARKET, BY IUI, 2021-2026 (IN $ MILLION)
FIGURE 38: UNITED STATES INFERTILITY TESTING & TREATMENT MARKET, BY IVF WITHOUT ICSI, 2021-2026 (IN $ MILLION)
FIGURE 39: UNITED STATES INFERTILITY TESTING & TREATMENT MARKET, BY SURROGACY, 2021-2026 (IN $ MILLION)
FIGURE 40: UNITED STATES INFERTILITY TESTING & TREATMENT MARKET, BY OTHERS, 2021-2026 (IN $ MILLION)
FIGURE 41: UNITED STATES INFERTILITY TESTING & TREATMENT MARKET, GROWTH POTENTIAL, BY END-USER, IN 2020
FIGURE 42: UNITED STATES INFERTILITY TESTING & TREATMENT MARKET, BY FERTILITY AND SURGICAL CENTERS, 2021-2026 (IN $ MILLION)
FIGURE 43: UNITED STATES INFERTILITY TESTING & TREATMENT MARKET, BY HOSPITALS AND RESEARCH LABORATORIES, 2021-2026 (IN $ MILLION)
FIGURE 44: UNITED STATES INFERTILITY TESTING & TREATMENT MARKET, BY CRYOBANKS, 2021-2026 (IN $ MILLION)

お問合せフォーム

プライバシーポリシーはこちらをご覧ください。